November 1, 2024
Ocular Hypertension Articles
November 1, 2024
A Novel Filtration Technique to Treat Open-angle Glaucoma
By Lilit Voskanyan, MD, PhD
November 1, 2024
Practical Tips for Using iStent Infinite
By Sahar Bedrood, MD, PhD
November 1, 2024
Optimizing Drop Size in Ophthalmic Applications
By Constance O. Okeke, MD, MSCE
September 1, 2024
Next-generation Drainage Implants
By Shivani S. Kamat, MD
September 1, 2024
Spotlight: An Option for Interventional Glaucoma
By Karen Appold, contributing writer
June 25, 2024
Trial Data Show Preservative-free Benefit for Glaucoma Treatment
June 1, 2024
Product Spotlight: The First Preservative-free Eye Drop for Glaucoma Debuts
By Karen Appold, contributing writer
June 1, 2024
An Update on Novel Devices to Measure Intraocular Pressure
By Alessandro A. Jammal, MD, PhD
June 1, 2024
Real-world Pearls for iDose TR Implantation
By Savak “Sev” Teymoorian, MD, MBA
June 1, 2024
Examining Bias in Published Surgical Glaucoma Clinical Trials
By Conni Koury, contributing editor
June 1, 2024
Positive Phase 2b Results for Bimatoprost-eluting Contact Lens
By Conni Koury, contributing editor
June 1, 2024
Positive Travoprost Implant Data Presented at ASCRS
By Conni Koury, contributing editor
June 1, 2024
Virtual Reality VF Test Accurate, Easy to Use at Home
By Conni Koury, contributing editor
June 1, 2024
Data on IOL-based Delivery of Bimatoprost Presented at ASCRS
By Conni Koury, contributing editor
June 1, 2024
IOP Lowering With Laser-guided Trabeculotomy Durable to 36 Months
By Conni Koury, contributing editor
June 1, 2024
Next-gen Lasers for Retina and Glaucoma Treatment Hit the Market
By Conni Koury, contributing editor
June 1, 2024
Novel IOP-lowering Product Targeting EVP, Distal Outflow Resistance Dosed in Phase 2
By Conni Koury, contributing editor
June 1, 2024
Switching to LBN Provided Additional IOP Lowering: Chart Review
By Conni Koury, contributing editor
June 1, 2024
KDB Glide Receives Expanded 510k Clearance
By Jim Gallagher, senior managing editor
April 19, 2024
Permanent J-code Assigned for iDose TR
By Jim Gallagher, senior managing editor
March 1, 2024
Travoprost Implant Noninferior to Twice-daily Timolol 0.5% Drops
By Conni Koury, contributing editor
December 1, 2023
Trials in Focus: The COAST Trial of Selective Laser Trabeculoplasty
By Tony Realini, MD, MPH
December 1, 2023
Fixed High-energy SLT Superior to Standard Titrated Protocol for IOP Lowering
By Conni Koury, contributing editor
September 1, 2023
First-in-Class, Dual-MOA Small-molecule Glaucoma Treatment Met Primary Endpoints in Phase 2a Trial
By Conni Koury, contributing editor
June 1, 2023
Iyuzeh Shows Similar IOP Lowering to Xalatan in Phase 3 Study
By Rochelle Nataloni, contributing writer
March 1, 2023
Visiox Submits NDA for First Once-daily Brimonidine
By Conni Koury, contributing editor
March 1, 2023
Six-year Results from LiGHT Trial Confirm SLT's Safety, Efficacy
By Conni Koury, contributing editor
December 16, 2022
Thea Pharma Receives FDA Approval for Iyuzeh Preservative-free Latanoprost
By Jennifer Ford, senior managing editor
September 1, 2022
From the Editor: Five Years of Glaucoma Physician
By Nathan M. Radcliffe, MD
September 1, 2022
Phase 2 Data Favorable for QLS-101 Safety, Efficacy
By Conni Koury, contributing editor
March 1, 2022
Study: Durysta Bimatoprost Implant Effective for OAG, Ocular Hypertension
By Conni Koury, contributing editor
March 1, 2022
COVID-19's Effect on Patient Adherence to Ocular Hypotensive Medication Studied
By Conni Koury, contributing editor
June 1, 2020
Nicox Clinical Trial Update
By Jerry Helzner, contributing editor
June 1, 2020
Study: Raising Eye Pressure Causes Glaucoma
By Jerry Helzner, contributing editor
March 1, 2020
Aerpio Has Good Early Data in Tie2 Regulation
By Jerry Helzner, contributing editor
Travoprost Intracameral Implant Launched
By Conni Koury, contributing editor
Advertisement
Recommendations
Advertisement